IBM today announced a multi-year, cognitive computing collaboration with the University of Maryland in Baltimore on an Accelerated Cognitive Cybersecurity Laboratory (ACCL). It’s the second such move in a month. In mid-April Big Blue announced plans for the Center for Cognitive Computing Systems Research (C3SR) to be based at the University of Illinois Urbana-Champaign.
Hong-Kong based Value Measured Investment Limited led a $10 million Series B financing in Sirnaomics, Inc., a biopharmaceutical company focusing on RNAi therapeutics. The funding will go towards development of anti-fibrosis treatments, with a Phase I clinical trial planned for early second half of 2016.
GenVec, Inc. (NasdaqCM: GNVC) (“GenVec” or “the Company”), today announced that it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $5 million in an at-the-market registered direct offering. The closing of the offering is expected to take place on or about May 10, 2016, subject to the satisfaction of customary closing conditions.
Johns Hopkins University President Ronald J. Daniels was among the panelists at the Milken Institute’s Global Conference last week, taking part in a discussion on how universities across the country are increasing their roles in regional economic development.
The panelists examined innovative models of collaboration with the private and government sectors that are spurring regional economic growth. They also discussed how universities are walking the tightrope of balancing a commitment to basic scientific research—where new knowledge is generated—with their desire and need to maximize returns from transferring technology to the private sector.
Kevin Haley doesn’t pay attention to the competition. As president of product and innovation for Under Armour, he encourages his team to ignore the noise and focus on their own game.
Kathy Snyder can go back to the beach now.
Snyder came out of retirement last year to once again take over the Maryland Chamber of Commerce when its CEO unexpectedly resigned. On Tuesday, the Chamber announced Snyder’s replacement, Christine Ross, currently the CEO of the Bonita Springs Area Chamber of Commerce in Florida, will take over the organization on July 11.
After six years of existence and raising more than $20 million, Personal Genome Diagnostics has its first full-time CEO.
Douglas Ward will head the Canton-based Johns Hopkins spinout and sit on its board, the company announced Monday.
According to Johns Hopkins researchers, every year due to birth defect, trauma or cancer, more than 200,000 people will need replacement bones in their face or skull. Typically, doctors would remove a part of the patient’s fibula and try to carve it into the required shape and implant the bone back into the patient’s face. While the procedure typically results in the bone regrowing and healing the damage in the face, it isn’t the ideal solution. Depending on the damage being corrected, the bone fragment often can’t be shaped to fit the face very well, which leaves the patient with significant scarring. The removal of part the fibula also creates trauma in the patient’s leg which, when combined with the ongoing trauma in their face or skull, can be quite stressful.
UMBC and IBM Research have announced an exciting new collaboration to create the Accelerated Cognitive Cybersecurity Lab (ACCL), opening at UMBC in fall 2016. Housed within the College of Engineering and Information Technology, the ACCL will advance scientific frontiers in cybersecurity and machine learning. The new lab is supported by a multi-year commitment from IBM.
The move to open an accelerator is part of the health system’s goal to create a place for personalized health ideas to “percolate,” says CEO Todd Stottlemyer.
